Alfa Wassermann SpA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- GDPH195154D
- Pages: 20
- September 2018
- Total Views:1290
- Region : Europe
- GlobalData
- Equity Research Report

Details
Summary
Alfa Wassermann SpA (Alfa Wassermann), a subsidiary of AlfaSigma SpA is a pharmaceutical company which produces and distributes drugs for human health. The company provides new discoveries in medicine, biology and genomics. Alfa Wassermann finds solutions for paradox treatment. The company offers self meditation products for sore throat, headaches, and muscle and joint pain treatments. It also provides antibiotics used for treatment of diseases such as vascular diseases, deep venous thrombosis and gastrointestinal tract diseases. Alfa Wassermann operates through its offices located in the US, the Netherlands, Mexico, France, Spain, Portugal, China, Poland, Romania, Tunisia and Slovakia. Alfa Wassermann is headquartered in Bologna, Italy.
Alfa Wassermann SpA-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table Of Content
Scope
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Alfa Wassermann SpA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Alfa Wassermann SpA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Alfa Wassermann SpA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Alfa Wassermann SpA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Alfa Wassermann SpA, Medical Devices Deals, 2012 to YTD 2018 9
Alfa Wassermann SpA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Alfa Wassermann SpA, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Alfa Wassermann Acquires Italian Operations from Sigma-Tau 11
Partnerships 13
Salix Pharma Enters Into Licensing Agreement With Alfa Wassermann For Rifaximin 13
Theravance and Alfa Wassermann Exercise of Options to Co-Develop For Velusetrag 14
Acquisition 15
Alfa Wassermann Acquires Promefarm 15
Alfa Wassermann SpA-Key Competitors 16
Alfa Wassermann SpA-Key Employees 17
Alfa Wassermann SpA-Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20
List Of Figure
List of Figures
Alfa Wassermann SpA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Alfa Wassermann SpA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Alfa Wassermann SpA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Alfa Wassermann SpA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Alfa Wassermann SpA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Alfa Wassermann SpA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Alfa Wassermann SpA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Alfa Wassermann SpA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Alfa Wassermann SpA, Medical Devices Deals, 2012 to YTD 2018 9
List Of Table
List of Tables
Alfa Wassermann SpA, Pharmaceuticals & Healthcare, Key Facts 2
Alfa Wassermann SpA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Alfa Wassermann SpA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Alfa Wassermann SpA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Alfa Wassermann SpA, Deals By Therapy Area, 2012 to YTD 2018 8
Alfa Wassermann SpA, Medical Devices Deals, 2012 to YTD 2018 9
Alfa Wassermann SpA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Alfa Wassermann Acquires Italian Operations from Sigma-Tau 11
Salix Pharma Enters Into Licensing Agreement With Alfa Wassermann For Rifaximin 13
Theravance and Alfa Wassermann Exercise of Options to Co-Develop For Velusetrag 14
Alfa Wassermann Acquires Promefarm 15
Alfa Wassermann SpA, Key Competitors 16
Alfa Wassermann SpA, Key Employees 17
Alfa Wassermann SpA, Other Locations 18
Alfa Wassermann SpA, Subsidiaries 18
Licence Rights
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
Section Purchase
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products and Companies
Products
Alfa Wassermann SpA, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Company Profile
Company Profile Title
Summary
Alfa Wassermann SpA (Alfa Wassermann), a subsidiary of AlfaSigma SpA is a pharmaceutical company which produces and distributes drugs for human health. The company provides new discoveries in medicine, biology and genomics. Alfa Wassermann finds solutions for paradox treatment. The company offers self meditation products for sore throat, headaches, and muscle and joint pain treatments. It also provides antibiotics used for treatment of diseases such as vascular diseases, deep venous thrombosis and gastrointestinal tract diseases. Alfa Wassermann operates through its offices located in the US, the Netherlands, Mexico, France, Spain, Portugal, China, Poland, Romania, Tunisia and Slovakia. Alfa Wassermann is headquartered in Bologna, Italy.
Alfa Wassermann SpA-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Scope
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Alfa Wassermann SpA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Alfa Wassermann SpA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Alfa Wassermann SpA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Alfa Wassermann SpA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Alfa Wassermann SpA, Medical Devices Deals, 2012 to YTD 2018 9
Alfa Wassermann SpA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Alfa Wassermann SpA, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Alfa Wassermann Acquires Italian Operations from Sigma-Tau 11
Partnerships 13
Salix Pharma Enters Into Licensing Agreement With Alfa Wassermann For Rifaximin 13
Theravance and Alfa Wassermann Exercise of Options to Co-Develop For Velusetrag 14
Acquisition 15
Alfa Wassermann Acquires Promefarm 15
Alfa Wassermann SpA-Key Competitors 16
Alfa Wassermann SpA-Key Employees 17
Alfa Wassermann SpA-Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20
List Of Figure
List of Figures
Alfa Wassermann SpA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Alfa Wassermann SpA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Alfa Wassermann SpA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Alfa Wassermann SpA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Alfa Wassermann SpA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Alfa Wassermann SpA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Alfa Wassermann SpA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Alfa Wassermann SpA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Alfa Wassermann SpA, Medical Devices Deals, 2012 to YTD 2018 9
List Of Table
List of Tables
Alfa Wassermann SpA, Pharmaceuticals & Healthcare, Key Facts 2
Alfa Wassermann SpA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Alfa Wassermann SpA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Alfa Wassermann SpA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Alfa Wassermann SpA, Deals By Therapy Area, 2012 to YTD 2018 8
Alfa Wassermann SpA, Medical Devices Deals, 2012 to YTD 2018 9
Alfa Wassermann SpA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Alfa Wassermann Acquires Italian Operations from Sigma-Tau 11
Salix Pharma Enters Into Licensing Agreement With Alfa Wassermann For Rifaximin 13
Theravance and Alfa Wassermann Exercise of Options to Co-Develop For Velusetrag 14
Alfa Wassermann Acquires Promefarm 15
Alfa Wassermann SpA, Key Competitors 16
Alfa Wassermann SpA, Key Employees 17
Alfa Wassermann SpA, Other Locations 18
Alfa Wassermann SpA, Subsidiaries 18
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products
Alfa Wassermann SpA, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.